Mark W. Kroll's most recent trade in Haemonetics Corp. was a trade of 1,400 Common Stock done at an average price of $70.6 . Disclosure was reported to the exchange on Nov. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp | Mark W. Kroll | Director | Purchase of securities on an exchange or from another person at price $ 70.56 per share. | 10 Nov 2025 | 1,400 | 24,757 (0%) | 0% | 70.6 | 98,784 | Common Stock |
| Haemonetics Corp | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 2,693 | 23,357 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 20,664 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 18,457 (0%) | 0% | - | Common Stock | |
| Axon | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 993 | 11,135 (0%) | 0% | 0 | Common Stock | |
| Axon | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 220.72 per share. | 07 Mar 2023 | 3,457 | 10,142 (0%) | 0% | 220.7 | 763,043 | Common Stock |
| Axon | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 220.85 per share. | 07 Mar 2023 | 92 | 13,599 (0%) | 0% | 220.8 | 20,318 | Common Stock |
| Haemonetics Corp | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 73.71 per share. | 15 Aug 2022 | 8,016 | 16,231 (0%) | 0% | 73.7 | 590,859 | Common Stock |
| Haemonetics Corp | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 24,247 (0%) | 0% | - | Common Stock | |
| Axon | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 102.82 per share. | 08 Jun 2022 | 3,159 | 13,691 (0%) | 0% | 102.8 | 324,796 | Common Stock |
| Axon | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 99.40 per share. | 20 May 2022 | 2,013 | 16,850 (0%) | 0% | 99.4 | 200,092 | Common Stock |
| Haemonetics Corp | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 21,517 (0%) | 0% | - | Common Stock |